Publications by authors named "Tim Van Kaem"

Claim this Profile
E
Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies.
Julie Desrivot, Tim Van Kaem, Lisa Allamassey, Eric Helmer

Clin Pharmacol Drug Dev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLPG1205, a GPR84 Modulator: Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects.
Helen Timmis, Tim Van Kaem, Julie Desrivot, Sonia Dupont, Luc Meuleners

Clin Pharmacol Drug Dev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects.
Florence Namour, René Galien, Tim Van Kaem, Annegret Van der Aa, Frédéric Vanhoutte

Br J Clin Pharmacol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis